DRWF has made a significant commitment to Islet Cell Research and Transplant both in the UK and around the world.
In 2004, we made an unprecedented grant to the Nuffield Department of Surgery at the Radcliffe Hospital, Oxford, for the provision of a Human Islet Isolation Facility.
The DRWF Human Islet Isolation Facility was launched in 2006 at the Churchill Hospital, Oxford. Housed within the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), this facility harvests human islets from donor pancreas for research and transplant. It plays a pivotal role in the supply of islets within the UK Islet Transplant Consortium (UKITC) for the delivery of an NHS funded national therapy for the treatment of Type 1 Diabetes.
Although only a small number of people can currently benefit from an Islet Transplant, it is our hope that research will continue to refine and improve current processes to enable it to become more widely available as a treatment option in future years.
‘Islet Cell Transplants – What you need to know’ is a patient document written by experts from within the UK Islet Transplant Consortium and made available as part of a national awareness campaign.